Manufacturer Provides High-Quality Artemisia Annua Extract Artemisinin

Artemisinin, also known as Qinghaosu, is an organic compound extracted from the plant Artemisia annua L. It is a sesquiterpene lactone peroxide with a molecular formula of C15H22O5 and a molecular weight of 282.34. Artemisinin is widely recognized as a novel anti-malarial drug, primarily used in the treatment of malaria caused by Plasmodium parasites. Its unique peroxide group allows it to activate and form free radicals that bind to and destroy the membranes of malaria parasites, leading to their death and ultimately curing the disease. In addition, Artemisinin has also been found to have other pharmacological effects such as anti-tumor, anti-diabetic, antifungal, immune modulation, antiviral, anti-inflammatory, and cardiovascular actions.

product details

Product Detail

Product Name	Artemisinin
Appearance	White Crystal Powder
Purity	99%
CAS	63968-64-9
Keywords	Artemisinin Powder
Storage	Keep in a cool, dry, dark location in a tightly sealed container or cylinder
Shelf Life	24 Months

Certificate of Analysis

Product name	Artemisinin	Manufacture date	Jan. 09 .2024
Batch number	BCSW240109	Analysis date	Jan. 10 .2024
Batch quantity	260KG	Expiry date	Jan. 08. 2026

ANALYSIS	SPECIFICATION	RUSULT
Assay by (HPLC)	99%	complies
Characters/appearance	White Crystal Powder	complies
Odor and taste	Characteristic	complies
Mesh size/sieve analysis	100% pass 80 mesh	complies
Loss on drying	<5%	1.26%
Tripolycyanamide	Negative	complies
Total ash	≤ 4.0 %	0.82%
Heavy Metals
As	≤2.0 ppm	negative
Pb	≤ 1.0 ppm	negative
Cd	≤ 0.5 ppm	negative
Hg	≤ 0.5 ppm	negative
Sum	≤ 20.0 ppm	negative
Microbiological quality	Ph. Eur. category 3A
Total Plate Count	<1000cfu/g	62 cfu/g
Yeast & Mold	<100cfu/g	8 cfu/g
E.Coli.	Negative	Negative
Salmonella	Negative	Negative
Packing & Storage	Keep in cool and dry place
Conclusion	Complies with in house standard

Application

Artemisinin, also known as Qinghaosu, has numerous applications primarily in the medical field. Its most significant use is in the treatment of malaria, a life-threatening disease caused by Plasmodium parasites. Artemisinin-based combination therapies (ACTs) are widely recommended by the World Health Organization (WHO) as the most effective treatment for uncomplicated malaria.

Beyond malaria, Artemisinin has also shown potential in treating other diseases. Its anti-tumor properties are being explored in clinical trials for various types of cancer. Furthermore, it has displayed anti-viral effects against viruses like influenza and dengue fever, though more research is needed.